A citation-based method for searching scientific literature

Esther Conde, Susana Hernandez, Rebeca Martinez, Barbara Angulo, Javier De Castro, Ana Collazo-Lorduy, Beatriz Jimenez, Alfonso Muriel, Jose Luis Mate, Teresa Moran, Ignacio Aranda, Bartomeu Massuti, Federico Rojo, Manuel Domine, Irene Sansano, Felip Garcia, Enriqueta Felip, Nuria Mancheño, Oscar Juan, Julian Sanz, Jose Luis Gonzalez-Larriba, Lidia Atienza-Cuevas, Esperanza Arriola-Arellano, Ihab Abdulkader, Jorge Garcia-Gonzalez, Carmen Camacho, Delvys Rodriguez-Abreu, Cristina Teixido, Noemi Reguart, Ana Gonzalez-Piñeiro, Martin Lazaro-Quintela, Maria Dolores Lozano, Alfonso Gurpide, Javier Gomez-Roman, Marta Lopez-Brea, Lara Pijuan, Marta Salido, Edurne Arriola, Amparo Company, Amelia Insa, Isabel Esteban-Rodriguez, Monica Saiz, Eider Azkona, Ramiro Alvarez, Angel Artal, Maria Luz Plaza, David Aguiar, Ana Belen Enguita, Amparo Benito, Luis Paz-Ares, Pilar Garrido, Fernando Lopez-Rios. J Thorac Oncol 2019
Times Cited: 25







List of co-cited articles
280 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC.
Jessica J Lin, Viola W Zhu, Adam J Schoenfeld, Beow Y Yeap, Ashish Saxena, Lorin A Ferris, Ibiayi Dagogo-Jack, Anna F Farago, Angela Taber, Anne Traynor,[...]. J Thorac Oncol 2018
34
4

Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non-Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study.
Enriqueta Felip, Filippo G de Braud, Michela Maur, Herbert H Loong, Alice Tsang Shaw, Johan F Vansteenkiste, Thomas John, Geoffrey Liu, Martijn P Lolkema, Giovanni Selvaggi,[...]. J Thorac Oncol 2020
18
5

Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
Hye Ryun Kim, Hyo Sup Shim, Jin-Haeng Chung, Young Joo Lee, Yun Kyoung Hong, Sun Young Rha, Se Hoon Kim, Sang-Jun Ha, Se Kyu Kim, Kyung Young Chung,[...]. Cancer 2012
105
4

Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer.
R Jonas A Nilsson, Niki Karachaliou, Jordi Berenguer, Ana Gimenez-Capitan, Pepijn Schellen, Cristina Teixido, Jihane Tannous, Justine L Kuiper, Esther Drees, Magda Grabowska,[...]. Oncotarget 2016
103
4

Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes.
Maria D Lozano, Javier J Zulueta, Jose I Echeveste, Alfonso Gúrpide, Luis M Seijo, Salvador Martín-Algarra, Anabel Del Barrio, Ruben Pio, Miguel Angel Idoate, Tania Labiano,[...]. Oncologist 2011
60
4

Antibody 1A4 with routine immunohistochemistry demonstrates high sensitivity for ALK rearrangement screening of Chinese lung adenocarcinoma patients: A single-center large-scale study.
Qiushi Wang, Lianhua Zhao, Xin Yang, Shirong Wei, Ying Zeng, Chengyi Mao, Li Lin, Ping Fu, Liang Lyu, Zengpeng Li,[...]. Lung Cancer 2016
10
10

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.
M Ilie, E Long, C Butori, V Hofman, C Coelle, V Mauro, K Zahaf, C H Marquette, J Mouroux, P Paterlini-Bréchot,[...]. Ann Oncol 2012
110
4

Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections.
Derek Atkins, Karl-August Reiffen, Conny Lund Tegtmeier, Henrik Winther, Marcellus S Bonato, Stephan Störkel. J Histochem Cytochem 2004
280
4


RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics.
Myron G Best, Nik Sol, Irsan Kooi, Jihane Tannous, Bart A Westerman, François Rustenburg, Pepijn Schellen, Heleen Verschueren, Edward Post, Jan Koster,[...]. Cancer Cell 2015
330
4

Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer.
Chye Ling Tan, Tse Hui Lim, Tony Kh Lim, Daniel Shao-Weng Tan, Yong Wei Chua, Mei Kim Ang, Brendan Pang, Chwee Teck Lim, Angela Takano, Alvin Soon-Tiong Lim,[...]. Oncotarget 2016
46
4

The anaplastic lymphoma kinase testing conundrum.
Esther Conde, Philippe Taniere, Fernando Lopez-Rios. Expert Rev Mol Diagn 2015
5
20

Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee.
Emina E Torlakovic, Søren Nielsen, Glenn Francis, John Garratt, Blake Gilks, Jeffrey D Goldsmith, Jason L Hornick, Elizabeth Hyjek, Merdol Ibrahim, Keith Miller,[...]. Appl Immunohistochem Mol Morphol 2015
57
4


ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment.
Greta Alì, Agnese Proietti, Serena Pelliccioni, Cristina Niccoli, Cristiana Lupi, Elisa Sensi, Riccardo Giannini, Nicla Borrelli, Maura Menghi, Antonio Chella,[...]. Arch Pathol Lab Med 2014
70
4



Clinicopathological characteristics of patients with non-small-cell lung cancer who harbor EML4-ALK fusion gene: a meta-analysis.
Fengzhi Zhao, Meng Xu, Honcho Lei, Ziqi Zhou, Liang Wang, Ping Li, Jianfu Zhao, Penghui Hu. PLoS One 2015
36
4

7
14

Monitoring and Characterization of Circulating Tumor Cells (CTCs) in a Patient With EML4-ALK-Positive Non-Small Cell Lung Cancer (NSCLC).
Michele Aieta, Antonella Facchinetti, Stefania De Faveri, Mariangela Manicone, Alfredo Tartarone, Luciana Possidente, Rosa Lerose, Giuseppina Mambella, Giuseppe Calderone, Rita Zamarchi,[...]. Clin Lung Cancer 2016
17
5

ALK and ROS1 testing on lung cancer cytologic samples: Perspectives.
Pasquale Pisapia, Maria D Lozano, Elena Vigliar, Claudio Bellevicine, Francesco Pepe, Umberto Malapelle, Giancarlo Troncone. Cancer Cytopathol 2017
27
4

Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
Marina Pekar-Zlotin, Fred R Hirsch, Lior Soussan-Gutman, Maya Ilouze, Addie Dvir, Theresa Boyle, Murry Wynes, Vincent A Miller, Doron Lipson, Gary A Palmer,[...]. Oncologist 2015
109
4

Custom Gene Capture and Next-Generation Sequencing to Resolve Discordant ALK Status by FISH and IHC in Lung Adenocarcinoma.
Jin Sung Jang, Xiaoke Wang, Peter T Vedell, Ji Wen, Jinghui Zhang, David W Ellison, Jared M Evans, Sarah H Johnson, Ping Yang, William R Sukov,[...]. J Thorac Oncol 2016
28
4

Clinical Implications of Variant ALK FISH Rearrangement Patterns.
Xin Gao, Lynette M Sholl, Mizuki Nishino, Jennifer C Heng, Pasi A Jänne, Geoffrey R Oxnard. J Thorac Oncol 2015
38
4

Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing.
Evgeny A Moskalev, Judith Frohnauer, Sabine Merkelbach-Bruse, Hans-Ulrich Schildhaus, Arno Dimmler, Thomas Schubert, Carsten Boltze, Helmut König, Florian Fuchs, Horia Sirbu,[...]. Lung Cancer 2014
21
4

Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials.
James H Suh, Adrienne Johnson, Lee Albacker, Kai Wang, Juliann Chmielecki, Garrett Frampton, Laurie Gay, Julia A Elvin, Jo-Anne Vergilio, Siraj Ali,[...]. Oncologist 2016
47
4

Variations in molecular profile in NSCLC can be analyzed using cytological samples: development of EGFR resistance mutations and coexistence of ALK-EML4 translocation in an EGFR-sensitive patient.
Maria D Lozano, Tania Labiano, Isabel Zudaire, Jose C Subtil, Alfonso Gúrpide, Jose I Echeveste, Javier J Zulueta, Salvador Martín-Algarra, Jose L Pérez-Gracia. Int J Surg Pathol 2015
7
14

ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma.
Sanja Dacic, Liza C Villaruz, Shira Abberbock, Alyssa Mahaffey, Pimpin Incharoen, Marina N Nikiforova. Oncotarget 2016
36
4

Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing.
Christina Selinger, Wendy Cooper, Trina Lum, Catriona McNeil, Adrienne Morey, Paul Waring, Benhur Amanuel, Michael Millward, Joanne Peverall, Chris Van Vliet,[...]. Histopathology 2015
14
7

Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma.
Yasushi Yatabe, Keitaro Matsuo, Tetsuya Mitsudomi. J Clin Oncol 2011
176
4


High-throughput diagnostic profiling of clinically actionable gene fusions in lung cancer.
Nicole Pfarr, Albrecht Stenzinger, Roland Penzel, Arne Warth, Hendrik Dienemann, Peter Schirmacher, Wilko Weichert, Volker Endris. Genes Chromosomes Cancer 2016
51
4

Review of Clinical Next-Generation Sequencing.
Sophia Yohe, Bharat Thyagarajan. Arch Pathol Lab Med 2017
102
4

Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma.
Seung Eun Lee, Boram Lee, Mineui Hong, Ji-Young Song, Kyungsoo Jung, Maruja E Lira, Mao Mao, Joungho Han, Jhingook Kim, Yoon-La Choi. Mod Pathol 2015
73
4

Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria.
Maximilian von Laffert, Arne Warth, Roland Penzel, Peter Schirmacher, Keith M Kerr, Göran Elmberger, Hans-Ulrich Schildhaus, Reinhard Büttner, Fernando Lopez-Rios, Simone Reu,[...]. J Thorac Oncol 2014
54
4

Anchored multiplex PCR for targeted next-generation sequencing.
Zongli Zheng, Matthew Liebers, Boryana Zhelyazkova, Yi Cao, Divya Panditi, Kerry D Lynch, Juxiang Chen, Hayley E Robinson, Hyo Sup Shim, Juliann Chmielecki,[...]. Nat Med 2014
464
4

Next-generation sequencing identifies and immunohistochemistry confirms a novel crizotinib-sensitive ALK rearrangement in a patient with metastatic non-small-cell lung cancer.
Nir Peled, Gary Palmer, Fred R Hirsch, Murry W Wynes, Maya Ilouze, Marileila Varella-Garcia, Lior Soussan-Gutman, Geoff A Otto, Philip J Stephens, Jeffrey S Ross,[...]. J Thorac Oncol 2012
105
4

Optimizing the DNA yield for molecular analysis from cytologic preparations.
Sinchita Roy-Chowdhuri, Chi-Wan Chow, Mary K Kane, Hui Yao, Ignacio I Wistuba, Savitri Krishnamurthy, John Stewart, Gregg Staerkel. Cancer Cytopathol 2016
28
4

Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing.
Natasha Rekhtman, Suzanne M Brandt, Carlie S Sigel, Maria A Friedlander, Gregory J Riely, William D Travis, Maureen F Zakowski, Andre L Moreira. J Thorac Oncol 2011
172
4


The combination of cytological smears and cell blocks on endobronchial ultrasound-guided transbronchial needle aspirates allows a higher diagnostic yield.
Ibrahim Onur Alici, Nilgün Yılmaz Demirci, Aydın Yılmaz, Funda Demirag, Jale Karakaya. Virchows Arch 2013
18
5

Use of capture-based next-generation sequencing to detect ALK fusion in plasma cell-free DNA of patients with non-small-cell lung cancer.
Shaohua Cui, Wei Zhang, Liwen Xiong, Feng Pan, Yanjie Niu, Tianqing Chu, Huimin Wang, Yizhuo Zhao, Liyan Jiang. Oncotarget 2017
44
4

Staining Performance of ALK and ROS1 Immunohistochemistry and Influence on Interpretation in Non-Small-Cell Lung Cancer.
Cleo Keppens, Jan von der Thüsen, Patrick Pauwels, Ales Ryska, Nils 't Hart, Ed Schuuring, Keith Miller, Erik Thunnissen, Karen Zwaenepoel, Elisabeth M C Dequeker. J Mol Diagn 2020
2
50

Improvement of cellularity on cell block preparations using the so-called tissue coagulum clot method during endobronchial ultrasound-guided transbronchial fine-needle aspiration.
Rex Chin Wei Yung, Susan Otell, Peter Illei, Douglas P Clark, David Feller-Kopman, Lonny Yarmus, Frederic Askin, Edward Gabrielson, Qing Kay Li. Cancer Cytopathol 2012
67
4

Real Clinical Practice in ALK-rearranged NSCLC Patients: A Retrospective Observational Study.
Shinichiro Okauchi, Takeshi Numata, Takeshi Nawa, Hideo Ichimura, Takefumi Saito, Kenji Hayashihara, Hideyasu Yamada, Hiroaki Satoh, Takeshi Endo, Yoshihisa Inage,[...]. Anticancer Res 2020
3
33

The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma.
Bryan L Betz, Catherine A Dixon, Helmut C Weigelin, Stewart M Knoepp, Michael H Roh. Cancer Cytopathol 2013
48
4

Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment.
Agnese Proietti, Greta Alì, Serena Pelliccioni, Cristiana Lupi, Elisa Sensi, Laura Boldrini, Adele Servadio, Antonio Chella, Alessandro Ribechini, Federico Cappuzzo,[...]. Cancer Cytopathol 2014
32
4

Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent.
Chris M J Conklin, Kenneth J Craddock, Cherry Have, Janessa Laskin, Christian Couture, Diana N Ionescu. J Thorac Oncol 2013
152
4

Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL.
Zandra C Deans, Jose Luis Costa, Ian Cree, Els Dequeker, Anders Edsjö, Shirley Henderson, Michael Hummel, Marjolijn Jl Ligtenberg, Marco Loddo, Jose Carlos Machado,[...]. Virchows Arch 2017
52
4

Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.
Yoshiyuki Suehara, Maria Arcila, Lu Wang, Adnan Hasanovic, Daphne Ang, Tatsuo Ito, Yuki Kimura, Alexander Drilon, Udayan Guha, Valerie Rusch,[...]. Clin Cancer Res 2012
125
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.